Company Overview of iTherX, Inc.
iTherX, Inc., a clinical stage pharmaceutical company, discovers and develops antiviral therapeutics for hepatitis C. It provides ITX-5061 to evaluate antiviral activity and safety in patients with hepatitis C virus infection. The company was formerly known as Immusol, Inc. and changed its name to iTherX, Inc. in December 2007. iTherX, Inc. was founded in 1992 and is based in San Diego, California.
700 West East Street
San Diego, CA 92101
Founded in 1992
Key Executives for iTherX, Inc.
Similar Private Companies By Industry
|Alvogen, Inc.||United States|
|Merial Select, Inc.||United States|
|Forgiven Bottling Group, Inc.||United States|
|Tensha Therapeutics, Inc.||United States|
|Glycan Biosciences Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact iTherX, Inc., please visit www.itherx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.